Frankee Swanson
Family Medicine · Washington, DCNPI 1659837664
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $646 and has fallen 55.2% since, to $289 in 2023.
Across 84 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$266
- Bausch Health US, LLC$231
- Takeda Pharmaceuticals U.S.A., Inc.$163
- Amgen$163
- Novo Nordisk$81
- Biohaven Pharmaceuticals, Inc.$80
- plus $540 from 13 others
What the payments were for
- Food & beverage$1,524100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $266 |
| Bausch Health US, LLC | 12 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $163 |
| Amgen | 11 | $163 |
| Novo Nordisk | 5 | $81 |
| Biohaven Pharmaceuticals, Inc. | 3 | $80 |
| Amarin Pharma, Inc. | 5 | $79 |
| Philips North America LLC | 3 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| Amneal Pharmaceuticals LLC | 4 | $60 |
| Boehringer Ingelheim | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Johnson & Johnson | 2 | $38 |
| AstraZeneca | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| GSK | 1 | $12 |
How this compares
$1,524 in reported general payments places this provider in the 85th percentile of 166 family medicine providers in District of Columbia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 14 | $123 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Washington
- Mark JohnsonWashington$38K
- Charles GreenWashington$25K
- Barry ClarkWashington$17K
- Joel AngWashington$14K
- Kandie TateWashington$12K
- Ghulam AbbasWashington$9K
- Megha MendirattaWashington$6K
- Minerva CamposWashington$5K
- Kathleen UhlWashington$5K
- Mikel HofmannWashington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.